Giulia Calciolari

🛡️ 𝘞𝘩𝘢𝘵 𝘥𝘰𝘦𝘴 𝘪𝘵 𝘳𝘦𝘢𝘭𝘭𝘺 𝘮𝘦𝘢𝘯 𝘵𝘰 𝘥𝘰 𝘣𝘶𝘴𝘪𝘯𝘦𝘴𝘴 𝘦𝘵𝘩𝘪𝘤𝘢𝘭𝘭𝘺 — 𝘯𝘰𝘵 𝘫𝘶𝘴𝘵 𝘪𝘯 𝘸𝘰𝘳𝘥𝘴, 𝘣𝘶𝘵 𝘪𝘯 𝘦𝘷𝘦𝘳𝘺𝘥𝘢𝘺 𝘥𝘦𝘤𝘪𝘴𝘪𝘰𝘯𝘴? At Bracco, ethical business is more than a policy. It’s a mindset that drives how we operate, every single day. That’s why we’re taking our commitment on the road: through our European 𝘊𝘰𝘮𝘱𝘭𝘪𝘢𝘯𝘤𝘦 𝘙𝘰𝘢𝘥𝘴𝘩𝘰𝘸, we’re bringing #transparency, #accountability, and shared #values directly to our teams and partners. Here’s just a glimpse of the progress we’re making: ✅ 100% of our Board trained on Model 231 and our Code of Ethics ✅ 73% of employees trained on anti-corruption — including all high-risk functions ✅ 100% of new suppliers qualified through Be Procurement, our vendor management portal As Anna Lisa Nicelli, Compliance Director EMEA, puts it: “𝘊𝘰𝘮𝘱𝘭𝘪𝘢𝘯𝘤𝘦 𝘮𝘦𝘢𝘯𝘴 𝘣𝘶𝘪𝘭𝘥𝘪𝘯𝘨 𝘵𝘳𝘶𝘴𝘵 𝘣𝘺 𝘥𝘰𝘪𝘯𝘨 𝘣𝘶𝘴𝘪𝘯𝘦𝘴𝘴 𝘸𝘪𝘵𝘩 𝘪𝘯𝘵𝘦𝘨𝘳𝘪𝘵𝘺.” And that’s exactly what we aim to do — making sure ethics and sustainability are embedded across our entire value chain. 👉 𝗖𝘂𝗿𝗶𝗼𝘂𝘀 𝘁𝗼 𝘀𝗲𝗲 𝗵𝗼𝘄 𝗲𝘁𝗵𝗶𝗰𝘀 𝗺𝗲𝗲𝘁𝘀 𝗮𝗰𝘁𝗶𝗼𝗻? 📖 Dive into the full story on 𝗽𝗮𝗴𝗲 𝟳𝟬 of our latest Sustainability Report: https://lnkd.in/dNfbc--j #SustainabilityAtTheCore #growth #BraccoCares #Sustainability #SustainableRadiology #SustainableHealthcare #ComplianceRoadshow

172

9 commenti

🫀 How do you enable fast, patient-centered decisions in complex cardiovascular care? At Policlinico Agostino Gemelli in Rome, Italy, Dr. Massimiliano Camilli and his heart team rely on SUITESTENSA to streamline collaboration, reduce diagnostic time, and enhance precision. By integrating multimodal imaging, advanced analysis, and AI-driven tools, the platform supports a tailored approach to even the most complex cardiac cases. In this video, Dr. Camilli shares his insights on how a modern Cardiovascular Information System (CVIS) must evolve—focusing on usability, advanced analytics, and full interoperability—to meet the clinical and operational needs of multidisciplinary teams. #cardiology #cardiovascular #AIinhealthcare #healthwithcare

70

In partnership with Ottobock, we are proud to share the results of our ASsessing Clinical outcomes with microprocEssor kNee uTilization in a K2 population (ASCENT K2) clinical trial —demonstrating how microprocessor knees (MPKs) significantly improve safety and preserve quality of life for those with above-knee amputations classified as limited community ambulators (Medicare K2 level). Led by researchers from the Hanger Institute for Clinical Research and Education and Ottobock, we worked in collaboration with the University of Washington and the University of Illinois Chicago to facilitate a randomized controlled trial, following over 100 participants across the U.S. over one year. The findings are clear: MPK users reported significantly fewer falls and less activity avoidance due to fear of falling compared to those using non-microprocessor knees. These results reinforce our commitment to evidence-based care and advocating for broader access to advanced prosthetic technology.  Read the full release here: https://lnkd.in/gJc4xmMf

117

2 commenti